Clinical islet transplantation achieves insulin independence in selected patients, yet current methods for extracting islets from their surrounding pancreatic matrix are suboptimal. The islet basement membrane (BM) influences islet function and survival and is a critical marker of islet integrity following rodent islet isolation. No studies have investigated the impact of islet isolation on BM integrity in human islets, which have a unique duplex structure. To address this, samples were taken from 27 clinical human islet isolations (donor age 41-59, BMI 26-38, cold ischemic time < 10 h). Collagen IV, pan-laminin, perlecan and laminin-a5 in the islet BM were significantly digested by enzyme treatment. In isolated islets, laminin-a5 (found in both layers of the duplex BM) and perlecan were lost entirely, with no restoration evident during culture. Collagen IV and pan-laminin were present in the disorganized BM of isolated islets, yet a significant reduction in pan-laminin was seen during the initial 24 h culture period. Islet cytotoxicity increased during culture. Therefore, the human islet BM is substantially disrupted during the islet isolation procedure. Islet function and survival may be compromised as a consequence of an incomplete islet BM, which has implications for islet survival and transplanted graft longevity.
Clinical islet transplantation achieves insulin independence in selected patients, yet current methods for extracting islets from their surrounding pancreatic matrix are suboptimal. The islet basement membrane (BM) influences islet function and survival and is a critical marker of islet integrity following rodent islet isolation. No studies have investigated the impact of islet isolation on BM integrity in human islets, which have a unique duplex structure. To address this, samples were taken from 27 clinical human islet isolations (donor age 41-59, BMI 26-38, cold ischemic time < 10 h). Collagen IV, pan-laminin, perlecan and laminin-a5 in the islet BM were significantly digested by enzyme treatment. In isolated islets, laminin-a5 (found in both layers of the duplex BM) and perlecan were lost entirely, with no restoration evident during culture. Collagen IV and pan-laminin were present in the disorganized BM of isolated islets, yet a significant reduction in pan-laminin was seen during the initial 24 h culture period. Islet cytotoxicity increased during culture. Therefore, the human islet BM is substantially disrupted during the islet isolation procedure. Islet function and survival may be compromised as a consequence of an incomplete islet BM, which has implications for islet survival and transplanted graft longevity.
Abbreviations: AK, adenylate kinase; BCA, bicinchoninic acid assay; BM, basement membrane; BSA, bovine serum albumin; CIT, cold ischemic time; DCD, donation after cardiac death; DMCU, dimethylcasein
Introduction
Clinical pancreatic islet transplantation has undergone huge advances over the past decade, with up to 85% of selected patients remaining insulin independent for at least a year posttransplantation in leading centers worldwide and the majority of transplanted patients achieving resolution of life-threatening hypoglycemic unawareness (1) (2) (3) (4) (5) . Results are, however, significantly influenced by the number and quality of the human islets that are transplanted, with a minimum of 8000 islet equivalents (IEQs) per kilogram required for consistent insulinindependence (6) .
In addition, current methods for isolating human islets are suboptimal, with transplantable islet yields obtained only from a small proportion of pancreases donated into clinical programs (7) . Optimizing human islet isolation remains a priority to ensure consistent islet yields from the full range of donated pancreases (8) . Indeed, the requirement to separate one intact organ (the islet) from within another organ (the pancreas), while maintaining structural integrity as well as viability, is a unique challenge.
To achieve optimal islet isolation requires delivery of collagenase blends to the pancreatic islet-exocrine interface to digest the extracellular matrix (ECM) and release intact islets from the surrounding exocrine tissue. The development of such enzyme blends requires a detailed understanding of the molecular ultrastructure of the islet-exocrine interface, before and during pancreas digestion.
The islet-exocrine interface is composed of an interstitial matrix and a basement membrane (BM).There is increasing evidence to suggest that, in addition to playing a structural role, the islet BM influences b-cell insulin secretion and survival (9) (10) (11) . BMs generally consist of a collagen IV network, which forms a scaffold into which the other BM components, including the laminins and heparan sulfate proteoglycan (HSPG) families, integrate in a highly organized, supramolecular architecture (12) . The human islet BM contains numerous laminin isoforms (13) as well as perlecan, the predominant HSPG (14) , which links laminins to collagen IV (15) . Laminins and HSPGs are implicated in multiple signaling pathways, conferring downstream signals for optimal cell survival and function (11, 12, 16, 17) .
It is well established that cell-matrix detachment can lead to anoikis (18, 19) . During islet isolation, not only is the interstitial matrix destroyed but also the BM may be partly digested. It is thought that the islet BM is a critical marker of islet integrity, with its disruption contributing to a reduction in islet number, viability, function and, therefore, transplant success (11, (20) (21) (22) . Although loss of islet BM during isolation and its subsequent remodeling following transplantation have been demonstrated in mouse islets (20) , no studies have investigated this in human islets.
Importantly, the human islet BM is unique. It exists as a duplex structure, consisting of a vascular BM associated with the islet capillary in addition to an endocrine BM integral to the islet itself (13) . The composition of each BM layer differs, but laminin-a5 is present in both layers (13) and can thereby be used as a marker for the integrity of the duplex BM. Mouse islets have only a single BM. This fact, along with substantial differences between the mouse and human in both islet structure and islet isolation procedures, suggests that a study investigating islet BM digestion in human islets is long overdue.
With current isolation methods, higher islet yields often result from donor pancreases that are "suboptimal" with regard to islet function and longevity, ie pancreases from older donors with high BMIs (23, 24) . It is hypothesized this is due to the "looser" structure of the pancreatic ECM of these donors compared with their younger, leaner counterparts. However, the function of islets isolated from younger donors is significantly better (24) (25) (26) , yet it remains difficult to consistently isolate transplantable yields from these donors. Knowledge of the composition and structure of the islet-exocrine interface (which is the "substrate" for digestion), even in "standard" (older, higher BMI) donors, is relatively incomplete, despite this donor group comprising around 55% of pancreases accepted for islet isolation in our center (27) . Characterization of the human islet BM will help optimize the efficiency of the digestion phase of human islet isolation, which will benefit islet yield, function and survival, thereby maximizing isolation success from the full range of donor pancreases.
The aim of this study was to characterize the digestion of key human islet BM components in pancreases from donors that fulfil the criteria for clinical transplantation (marginal donors were excluded). To do this, we studied BM composition of (i) islets in situ in the human pancreas, (ii) islets immediately following isolation, and (iii) cultured islets prior to transplantation.
Materials and Methods

Islet isolation and sampling technique
With appropriate consent and ethical approval, human pancreases (n = 27) were procured from multiorgan donors ( Table 1 ). Islets were isolated using conventional methods comprising intraductal enzyme infusion using collagenase NB1 (2101-2965 PZU) and neutral protease NB (NP; 50 dimethylcasein unit [DMCU]; Serva, Heidelberg, Germany), followed by semiautomated digestion and continuous density gradient purification (28, 29 
Islet viability
Viability was measured postisolation, and at 24, 48 and 72 h culture for a subset of islet preparations, by incubating a small sample of islets for 3 min with fluorescein diacetate (0.1 mg/mL; Sigma), which stains live cells green, and ethidium bromide (0.1 mg/mL; Sigma), a red dye that can permeate only cells with damaged membranes. The percentage of dead cells per islet was approximated by visual enumeration using a fluorescent microscope.
Islet cytotoxicity
Cytotoxicity was assessed in cultured islets. Supernatant samples were collected preculture and at 24, 48 and 72 h of culture and were stored at À25°C. The release of adenylate kinase (AK) from damaged cells was measured using a ToxiLight bioassay kit (Lonza), according to the manufacturer's instructions. Results are expressed as percentage of control (precultured samples).
Islet function
In vitro islet function was assessed in triplicate during static incubation (30) . Ten to 12 hand-picked and size-matched islets per tube were preincubated in Krebs-Ringer bicarbonate buffer (KRBB) supplemented with 2 mg/mL bovine serum albumin (BSA) (Sigma) and 1 mmol/L glucose (Sigma) for 1 h at 37°C, followed by 1 h incubation in KRBB with 20 mmol/L glucose at 37°C. Insulin secretion was determined by radioimmunoassay (Millipore, Livingstone, UK). Stimulation index was calculated by dividing insulin release at 20 mmol/L glucose by insulin release at 1 mmol/L glucose.
Enzymatic treatment and immunolabeling of tissue sections
Pancreatic tissue sections (10 lm) were prepared using a Cryostat (Leica, Milton Keynes, UK), collected onto Superfrost glass slides (Thermo-Fisher Scientific, Loughborough, UK) and stored at À25°C. Sections were incubated for 2 or 5 min at 37°C with clinically comparable concentrations of collagenase (6.56 PZU/mL) and NP (0.14 DMCU/mL) or with Hank's Balanced Salt Solution (HBSS) (control), and then treated with cold running water to stop enzymatic activity. Sections were fixed with 2.5% paraformaldehyde, blocked with 5% goat serum (Vector Laboratories, Peterborough, UK) for 1 h, and then incubated with primary antibodies for 1 h at room temperature (r.t.): polyclonal rabbit anti-pan-laminin, polyclonal rabbit anticollagen IV, monoclonal mouse antiperlecan and monoclonal mouse anti-laminin-a5 (all Abcam, Cambridge, UK) along with polyclonal guinea pig anti-insulin (DAKO, Ely, UK). Sections were then treated with secondary antibodies: AlexaFluor488-conjugated goat antirabbit (Thermo-Fisher Scientific), CFL488-conjugated goat antimouse (Santa Cruz Biotechnology, Dallas, TX) and Texas red-conjugated goat anti-guinea pig (Vector Laboratories) for 0.5 h at r.t., and then mounted using Vectashield HardSet mounting media (Vector Laboratories).
Quantitative analysis of islet BM components during digestion
A minimum of 6 islets per donor per condition were imaged using an Axioskop 40 light microscope (Carl Zeiss, Jena, Germany). Eight-bit blackand-white images were taken using Axiovision software. A semiautomated, quantitative measurement of the area and fluorescent intensity of each islet was carried out using an in-house macro in ImageJ. Islet area was exclusively selected as the region of interest (ROI) using the insulin staining signal. Peri-and intraislet protein area and fluorescent signal above the defined threshold were measured within the ROI. Protein area was normalized against islet area, and then multiplied by the mean signal intensity, with the treatment data further normalized against the controls.
Islet immunolabeling
Whole islets were immunofluorescently labeled to determine BM protein localization. Following three washes in phosphate buffered saline (PBS) containing 0.05% Tween (Sigma), islets were blocked with 5% goat serum and permeabilized with 0.1% Triton (Sigma) for 0.5 h at r.t. Islets were incubated with primary antibodies as above for 2 h, and then with secondary antibodies as above for 1 h. Islets were viewed and images captured using a Zeiss LSM510 confocal laser scanning microscope. The quantity of BM protein was estimated by visual enumeration using a numerical scoring system, from 0 (no protein present) to 3. An average of 8 islets were scored per sample.
Protein extraction and quantification
Protein was extracted from islets by homogenization in ice-cold radioimmunoprecipitation assay (RIPA) buffer (Sigma). A bicinchoninic acid assay (BCA) assay was used to quantify total protein according to the manufacturer's instructions (Thermo-Fisher Scientific).
ELISAs
To quantify the amount of BM protein at each time point, islet lysates were analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for pan-laminin (Abcam), collagen IV, laminin-a5 and perlecan (all USCN Life Science, Wuhan, China) according to the manufacturer's instructions. Ten micrograms of protein were loaded per well. Results are expressed as nanograms per milliliter.
Transmission electron microscopy and serial block facescanning electron microscopy
Isolated islets (n = 3) and intact pancreatic tissue samples (n = 3) were fixed and processed using a high-density staining method suitable for block face imaging as previously described (31, 32) . For further details, see Data S1.
Statistical analysis
Data are expressed as mean AE SEM. Multiple experimental conditions were compared using linear mixed modeling (for slide-based digestion experiments) and one-way ANOVA followed by post hoc Tukey's or Kruskal-Wallis tests, with post hoc Dunn's test for multiple comparisons (for islet viability, cytotoxicity, immunolabeling and ELISAs). Correlation analysis assessed associations between islet BM loss and donor and islet isolation parameters, with Pearson or Spearman correlation coefficients used as appropriate. p < 0.05 was considered significant. The software packages Prism-Graphpad (Graphpad, San Diego, CA) and SPSS Statistics (IBM, Portsmouth, UK) were used.
Results
Islet isolations were performed on 27 pancreases from "standard" donors (median age = 52, range 41-59; median BMI = 30, range 26-38) accepted for clinical islet transplantation. Yield was 209 000 AE 18 000 IEQs, purity was 61 AE 3% and viability was 77 AE 2% ( Table 1) .
Composition of the human islet BM Collagen IV, pan-laminin, perlecan and the laminin-a5 isoform were found to be major components of the BM of islets in situ within the human pancreas ( Figure 1A ). Enzyme treatment of pancreas sections resulted in significant digestion of collagen IV and pan-laminin in the islet BM (Figures 1A and B ; p < 0.05). A 35 AE 8% reduction in the quantity of laminin-a5 in the islet BM was seen after 2 min of enzyme treatment, with a 45 AE 6% reduction observed following 5 min of treatment (Figures 1A and B; p < 0.05). Perlecan was most susceptible to enzyme treatment, with significant digestion observed following both 2 (53 AE 7% reduction) and 5 min (67 AE 6% reduction) of treatment (Figures 1A and B ; p < 0.05). Immunolabeling control experiments showed no background signal or cross-reactivity between antibodies ( Figure S1 ).
Localization of BM proteins in isolated islets
Immunostaining of precultured islets revealed a total loss of perlecan and laminin-a5, indicative of substantial BM damage during islet isolation (Figures 2C and D) . Collagen IV and pan-laminin labeling was, however, present in precultured islets and appeared to follow the intraislet capillary tracts (Figures 2A and B) . A 46 AE 14% reduction in pan-laminin labeling over the first 24 h of culture was seen (p < 0.01), with expression then remaining stable for the final 48-h culture period (Figures 2B , F, H, J, and K). A trend toward a reduction in collagen IV over time was found (36 AE 16% reduction 0-48 h culture, p = ns; Figures 2A, E, G, I , and K), with labeling for both perlecan and laminin-a5 remaining absent throughout the 72-h culture period ( Figure 2K ; images not shown).
Quantification of BM proteins
The results generated by ELISA represent the total amount of protein present in the islet preparation, regardless of whether the protein is present in islets themselves or in acinar tissue, and is influenced by the purity of the sample. Therefore, all ELISA results have been corrected for the purity of each respective islet preparation. Despite this, it is important to consider the results of immunostaining and ELISAs in parallel.
A 62 AE 10% reduction in pan-laminin during the first 24 h of culture was found (8.6 AE 1.8 vs. 3.3 AE 0.9 ng/ mL, precultured vs. 24-h culture, p < 0.05, Figure 3 ). The quantity of pan-laminin present at 48 and 72 h was also significantly reduced compared to precultured islets (p < 0.01). Collagen IV was unchanged over the 72-h culture period ( Figure 3 ). Quantities of laminin-a5 and perlecan were around the lower detection limits of the respective ELISAs, correlating with the lack of positive labeling seen using islet immunostaining.
Ultrastructural assessment of the islet BM
In the intact pancreas, islets are enclosed in an encapsulating BM structure ( Figures 4A,i) . Transmission electron microscopy (TEM) reveals the double leaflet organization of the BM and close association of the islet with extraislet capillaries ( Figure 4A ). Collagen fibers appear uniform in their organization without crosslinking. By contrast, no BM structure is visible in isolated islets ( Figure 4A ,ii). To further define the loss of islet BM, serial block facescanning electron microscopy (SBF-SEM) was used to serially section isolated islets ( Figure 4B ). Through 100-nm serial sections, no organization to the islet BM was identified ( Figure 4B ,ii).
Effect of islet BM disruption on islet survival
During culture, no change in islet viability was observed ( Figure 5A ), yet assessment of islet cell cytotoxicity showed an increase in the release of AK ( Figure 5B ). This increase in cytotoxicity mirrors the loss of panlaminin from islets over time in culture (shown in Figures 2 and 3 ) and may result from the extensive loss of perlecan and laminin-a5 seen during the digestion process (shown in Figures 2C and D) .
Correlation of islet BM loss with donor and islet isolation parameters
Correlations were performed to assess associations between donor and islet isolation parameters and loss of pan-laminin in the islet BM. Because perlecan and laminin-a5 were lost entirely in all islet preparations studied, and collagen IV was present postisolation, remaining stable during culture, correlation analysis was not possible for these datasets. Pan-laminin content of precultured islets showed a negative correlation with pancreas cold ischemic time (CIT; r = À0.75, p < 0.01; Figure 6A ). The pan-laminin content of 24-h cultured islets was negatively correlated with pancreas CIT (r = À0.75, p < 0.01; Figure 6B ) and positively correlated with islet yield (islet number; r = 0.72, p < 0.05; Figure 6C ).
Discussion
The fate of human islet BM components following islet isolation has not been reported, despite previous studies demonstrating BM loss in rodent islets (20) . This study, using in vitro digestion experiments combined with analysis of intact pancreatic tissue, isolated and cultured islets, has determined that key components of the human islet BM are differentially digested during islet isolation and that the BM fails to recover during islet culture prior to transplantation.
Our results confirm and extend those of Virtanen et al (13) , demonstrating the presence of collagen IV and laminin-a5 in both layers of the islet double BM. Importantly, our study found for the first time that both laminin-a5 and perlecan are lost entirely in isolated islets, indicating that extensive BM disruption occurs during islet isolation, which has potentially major translational significance. Laminin-a5 and perlecan appear particularly sensitive to digestive enzyme treatment, and this apparent breach of the endocrine BM layer may severely compromise islet cell function and survival. The disorganized islet BM that remains following islet isolation contains collagen IV and pan-laminin. Substantial remodeling or restructuring did not occur during culture, with a decrease in pan-laminin observed during the initial 24 h of culture and collagen IV remaining stable. No recovery of laminin-a5 or perlecan was evident during culture. Cytotoxicity increased during culture, echoing the loss of laminin from cultured islets, thereby suggesting that BM disruption and loss of laminins and perlecan may have a deleterious impact on islet survival.
Loss of laminin-a5 during culture has been reported in isolated canine islets (33) . However, perlecan was found to be absent in isolated mouse islets (20) , which is in agreement with our results in human islets. Mouse islets lose collagen IV during isolation, with no recovery during culture (20) , yet our results show the presence of collagen IV in isolated human islets. This inconsistency between mouse and human islets is likely due to considerable differences in BM structure between species (13) and in islet isolation procedures.
Our results indicate that the BM is not lost as a whole at the same rate, but instead that certain components are more vulnerable to digestion. This could be due to differing effects of each component of the collagenase enzyme blend or that the loss of surrounding tissue affects the integrity of specific proteins more than others. In the BM, members of the laminin family bind The amount of BM protein present at each time point was scored visually. Significant differences in pan-laminin content were seen between precultured islets and cultured islets (**p < 0.01 vs. precultured islets). Although there was a trend toward a reduction in collagen IV over time, this did not reach significance. Data represent each individual islet isolation, along with mean AE SEM from n = 8-17 islet preparations. BM, basement membrane.
to the cell surface through interactions with their cellular receptors. Laminins are linked to the collagen IV network via collateral interactions with perlecan and nidogen, forming a highly structured BM (15) . Disruption of any component compromises BM integrity. Furthermore, an incomplete BM potentially exposes proteins originally hidden within the specialized architecture, allowing access of digestion enzymes and further BM breakdown. The two layers of the human islet BM have distinctly different organization (13) and so would be expected to differ in their susceptibility to digestion. Therefore, it will be important to investigate the loss of additional BM components, such as nidogen (20) and other laminin isoforms (13) . Analysis of the islet BM during and post-islet isolation will enable the effective evaluation of digestion enzymes, with studies under way in our laboratory to determine the exact substrates of each component of the clinically used enzyme blends. Identification of matrix proteins unique to the peri-and intraislet BM will help the development of novel, targeted enzyme blends. Laminin-b2 is prominent only in the intraislet vascular BM, with laminin-a2 comprising the BM of exocrine cells only (13) . Laminin-a2 could therefore represent a target for tailored enzymes, which would cleave only the specific matrix proteins surrounding the islet, thereby freeing islets from their supporting exocrine tissue while leaving important intraislet BMs intact.
Many clinical islet isolation centers, including our own, have adopted a short period of islet culture (<48 h) prior to transplantation (34) . This provides an opportunity for islet quality assessment, recipient matching, transport of islets and recipients to the transplant center, and initiation of immunosuppressive protocols. However, integral to this culture period is the risk of islet loss. It was therefore important to study the effect of culture on the islet BM. Isolated islets retained collagen IV, but pan-laminin was lost during culture. This contrasts with the extensive digestion of laminin-a5 and perlecan during islet isolation, with no evidence of restoration during culture. It is important to note that, in our center, islet culture conditions prior to transplantation are minimal in composition (CMRL media supplemented with 2% HSA and 2 mmol L-glutamine).
Studies are under way in our laboratory to investigate whether modifications to culture conditions, including supplementation with human AB serum and combinations of matrix proteins, will enable the preservation and recovery of islet BM and thus improve islet function and survival. It will also be necessary to investigate recovery and remodeling of the human islet BM posttransplantation and its impact on islet engraftment using an in vivo model.
BMs provide a barrier function, structural support and vital signaling for adjacent cells. The majority of b cells in native islets are in contact with BM; therefore, its preservation is crucial for maintaining optimal islet function (22) . Laminins interact with islet cells via receptors, including integrins (13, 35) and Lutheran glycoproteins (13) , conferring downstream biochemical pathways (12, 16, 36) . Integrins avb3 and avb5 regulate adhesion and differentiation, with a3b1 and a6b1 involved in insulin secretion (37) (38) (39) . Notably, our study found a positive correlation between islet yield and laminin content following 24-h culture, suggesting that substantial loss of laminin and other components of the BM may affect islet survival pretransplantation. Heparan sulfate (HS) has recently been shown to play a role in b cell survival and differentiation (40, 41) and in protection against reactive oxygen species-induced damage (17, 40) . HSPGs, including perlecan, are composed of HS chains attached to individual core proteins (42) (43) (44) (45) (46) . During mouse islet isolation, HS is lost and fails to recover during culture (17) , yet, importantly, antioxidant treatment preserved HS during islet isolation, resulting in a significant improvement in islet survival (17) . This suggests that loss of perlecan during human islet isolation, as demonstrated in our study, may substantially affect islet viability and function; indeed, the extensive loss of perlecan was evident in all islet preparations studied, with the mean viability being 77 AE 2%. Therefore, the use of antioxidant treatment for preservation of HS during human islet isolation warrants further investigation.
Pancreas shortage is a primary factor preventing islet transplantation from being made available to more patients. It is therefore increasingly common for Graph shows the amount of collagen IV and pan-laminin present in isolated islet preparations over 72 h in culture, as measured using ELISA. The level of collagen IV remained stable over the entire culture period. A significant reduction in pan-laminin expression compared to precultured islets was seen at each time point (*p < 0.05, **p < 0.01, ***p < 0.001 vs. precultured islets). A trend toward the further loss of pan-laminin after the initial 24-h culture period was seen but did not reach significance. Data are mean AE SEM, corrected for purity, from n = 10-15 islet preparations. BM, basement membrane.
pancreases from marginal donors to be offered for islet transplantation, yet isolation results from these pancreases are frequently suboptimal. This study could be extended to include marginal donors, for example, pancreases from young donors and donation after cardiac death (DCD) donors. This knowledge will help optimize and tailor the islet isolation process for the full range of donors, thereby increasing the available pancreas donor pool. Caution is, however, needed because our results suggest that pancreas CIT influences the susceptibility of pan-laminin to digestion during islet isolation, with islets isolated from pancreases with shorter CITs retaining a greater quantity of pan-laminin. Islets from higheryielding isolations appear to retain greater quantities of pan-laminin following 24-h culture, suggesting that loss of laminin during islet isolation and culture could be contributing to poorer isolation outcomes with reduced islet survival.
The current focus on developing islet scaffolds, both preand postimplantation (47) (48) (49) (50) (51) (52) (53) (54) , means a detailed understanding of the normal molecular structure of the pancreas is important. One aim of such scaffolds is to support islet survival by providing essential cell-to-matrix interactions, which may be lost during islet isolation. By characterizing the impact of islet isolation on the human islet BM, this study has contributed significant data that will aid in the development of islet scaffolds.
The loss of BM may negatively affect islet survival and be a contributory factor to the need for the excessively large number of islets required for islet transplantation to be successful. This study has characterized the human islet BM and its disruption during islet isolation in pancreases from the "standard" donor typically accepted for islet isolation. We aim to extend our investigations to study the islet BM in the full range of donor pancreases. This detailed characterization will have huge translational potential, for optimizing digestion enzyme blends and isolation techniques as well as for the development and bioengineering of scaffolds and encapsulation technologies. Disclaimer
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